CVR number 41220589
Industry 86.9090 Other human health activities

Rydiger Nielsen ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  0.0% 10.1% 7.3% 7.3% 9.8%  
Credit score (0-100)  0 24 32 33 24  
Credit rating  N/A BB BBB BBB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 -93.1 -45.6 -16.0 -3.0  
EBITDA  0.0 -134 -45.6 -16.0 -3.0  
EBIT  0.0 -148 -59.2 -29.5 -18.8  
Pre-tax profit (PTP)  0.0 -148.3 -59.2 -29.5 -18.8  
Net earnings  0.0 -148.3 -59.2 -29.5 -18.8  
Pre-tax profit without non-rec. items  0.0 -148 -59.2 -29.5 -18.8  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 65.4 51.9 38.3 24.7  
Shareholders equity total  0.0 -99.2 -158 -187 -199  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 75.6 52.6 47.1 27.1  
Net Debt  0.0 -10.1 -0.8 -8.8 -2.4  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -93.1 -45.6 -16.0 -3.0  
Gross profit growth  0.0% 0.0% 51.0% 65.0% 81.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 76 53 47 27  
Balance sheet change%  0.0% 0.0% -30.3% -10.5% -42.5%  
Added value  0.0 -133.7 -45.6 -16.0 -3.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 51 -27 -27 -29  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 159.2% 129.7% 185.1% 634.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -84.8% -30.8% -13.3% -8.2%  
ROI %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROE %  0.0% -196.3% -92.4% -59.2% -50.7%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% -56.8% -75.0% -79.9% -88.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 7.6% 1.7% 55.1% 79.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.1 0.0 0.1 0.0  
Current Ratio  0.0 0.1 0.0 0.1 0.0  
Cash and cash equivalent  0.0 10.1 0.8 8.8 2.4  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -89.7 -99.6 -101.0 -107.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0